Table 2.
Demographic data and medical therapy.
| Patient | Gender | Age | Smoker | Disease Duration | Therapy |
|---|---|---|---|---|---|
| Case 1 | M | 32 | former | 10 years 5 months | 5-ASA |
| Case 2 | M | 30 | active | 8 years 4 months | CS, IFX, ADA |
| Case 3 | F | 51 | no | 8 months | 5-ASA, CS |
| Case 4 | M | 45 | active | 1 years 5 months | 5-ASA, CS |
| Case 5 | F | 61 | active | 25 years 7 months | CS, IFX, ADA |
| Case 6 | M | 64 | former | 33 years | 5-ASA, CS |
| Case 7 | M | 36 | active | 5 years 9 months | 5-ASA |
| Case 8 | M | 58 | no | 11 years 5 months | 5-ASA, CS |
| Case 9 | M | 52 | active | 7 months | none |
| Case 10 | F | 48 | former | 1 years 4 months | 5-ASA, CS |
| Case 11 | M | 56 | no | 12 years 3 months | 5-ASA, CS |
| Case 12 | F | 35 | no | 5 years 10 months | 5-ASA, CS, ADA |
| Case 13 | M | 32 | no | 7 years 2 months | CS, IFX |
| Case 14 | F | 49 | former | 21 years 7 months | 5-ASA, IFX |
| Case 15 | F | 22 | no | 7 years 2 months | 5-ASA, AZA |
| Case 16 | F | 62 | former | 1 years 10 months | 5-ASA, CS |
| Case 17 | F | 63 | former | 1 years 6 months | none |
| Case 18 | M | 19 | no | 3 months | 5-ASA, CS |
| Case 19 | M | 33 | active | 6 years 2 months | 5-ASA, AZA |
| Case 20 | F | 20 | no | 11 months | 5-ASA, CS |
| Case 21 | M | 22 | former | 1 years | 5-ASA, IFX |
| Case 22 | M | 33 | active | 4 years 7 months | CS |
| Case 23 | M | 32 | active | 5 years 10 months | 5-ASA, CS, AZA |
5-ASA = Mesalazine; CS = Corticosteroid; IFX = Infliximab; ADA = Adalimumab; AZA = Azathioprine.